Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.

Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system, which affects over 2.5 million people worldwide. Although MS has been extensively studied, many challenges still remain in regards to treatment, diagnosis and prognosis.